JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene. Agnihotri SP, Dang X, Carter JL, Fife TD, Bord E, Batson S, Koralnik IJ Neurology. 2014 Jul 18. PMID: 25037207. Abstract CommentRecommendBookmarkWatch